- Transient elastography, true or false?
-
Seo YS
- KMID: 1384050
- Korean J Hepatol.
- 2009 Dec;15(4):431-437.
- doi: 10.3350/kjhep.2009.15.4.431
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- A Case of Bell's Palsy Associated with Peginterferon Alfa-2a and Ribavirin Therapy for Chronic Hepatitis C Virus Infection
-
Lee MY, Cho H, Kim YM, Lee JS
- KMID: 760677
- Korean J Hepatol.
- 2006 Sep;12(3):444-448.
Pegylated interferon alfa-2a (PEG-IFN) and ribavirin combination therapy is the first line treatment for chronic HCV infection. There are four reports of Bell's palsy associated with interferon-alpha (IFN-alpha) and ribavirin... -
- CITED
-
- Close
- SHARE
-
- Close
- Review: Clinical Outcome after Living Donor Liver Transplantation in Patients with Hepatitis C Virus-associated Cirrhosis
-
Kim HJ
- KMID: 1776824
- Korean J Hepatol.
- 2007 Dec;13(4):489-494.
- doi: 10.3350/kjhep.2007.13.4.489
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- A Case of Pegylated Interferon Alpha-2a Monotherapy in a Peritoneal Dialysis Patient with Chronic Hepatitis C
-
Tae HJ, Jun DW, Choi JW, Kim WJ, Kim BY, Sohn JH, Lee MH
- KMID: 1718419
- Korean J Gastroenterol.
- 2011 Aug;58(2):107-110.
- doi: 10.4166/kjg.2011.58.2.107
Pegylated interferon (PEG-IFN) is now the standard treatment for chronic hepatitis C. But, there are few reports about patients with end stage renal disease, and treatment protocol for HCV infection... -
- CITED
-
- Close
- SHARE
-
- Close
- Synchronous Hepatocellular Carcinoma and B-Cell Non-Hodgkin's Lymphoma in Chronic Hepatitis C Patient
-
Lee SI, Heo NY, Park SH, Joo YD, Kim IH, Park JI, Kim JY, Kim SH, Shim HK
- KMID: 2160660
- Korean J Gastroenterol.
- 2014 Sep;64(3):168-172.
- doi: 10.4166/kjg.2014.64.3.168
Hepatitis C virus (HCV) is one of the main viral causes of hepatocellular carcinoma (HCC) and is associated with lymphoproliferative disorder such as non-Hodgkin's lymphoma (NHL). However, there are only... -
- CITED
-
- Close
- SHARE
-
- Close
- Durability of Sustained Virologic Response in Chronic Hepatitis C: Analysis of Factors Related to Relapse after Sustained Virologic Response with Peginterferon Plus Ribavirin Combination Therapy
-
Lee JE, Yoon NR, Kim JD, Song MJ, Kwon JH, Bae SH, Choi JY, Jeong SW, Yoon SK
- KMID: 1128356
- Korean J Gastroenterol.
- 2011 Mar;57(3):173-179.
- doi: 10.4166/kjg.2011.57.3.173
BACKGROUND/AIMS: Pegylated interferon plus ribavirin combination therapy has been the standard of therapy for patients with chronic hepatitis C. Although previous studies have reported long term durability after the sustained... -
- CITED
-
- Close
- SHARE
-
- Close
- Interstitial Pneumonitis in a Patient with Chronic Hepatitis C and Chronic Renal Failure on Interferon Therapy
-
Kang EJ, Kim DK, Jeon SR, Choi HS, Jeong SW, Jang JY, Lee JS, Uh ST
- KMID: 1792815
- Korean J Gastroenterol.
- 2011 Jul;58(1):47-52.
- doi: 10.4166/kjg.2011.58.1.47
After 4-months of alpha interferon (IFN-alpha), a 64-year old woman with chronic hepatitis C developed a cough and dyspnea and showed diffuse infiltrative opacities on her chest X-ray. Her symptoms... -
- CITED
-
- Close
- SHARE
-
- Close
- Advanced fibrosis is not a negative pretreatment predictive factor for genotype 2 or 3 chronic hepatitis C patients
-
Lee HS, Kweon YO, Tak WY, Park SY, Kang EJ, Lee YL, Yang HM, Park HW
- KMID: 1776802
- Clin Mol Hepatol.
- 2013 Jun;19(2):148-155.
- doi: 10.3350/cmh.2013.19.2.148
BACKGROUND/AIMS: Chronic hepatitis C patients with advanced fibrosis have unsatisfactory sustained virological response (SVR) rates. Few data demonstrating the efficacy of combination therapy in chronic hepatitis C patients with advanced... -
- CITED
-
- Close
- SHARE
-
- Close
- Development of ocular myasthenia during pegylated interferon and ribavirin treatment for chronic hepatitis C
-
Kang HM, Park MJ, Hwang JM, Kim JW, Jeong SH
- KMID: 1381442
- Korean J Hepatol.
- 2009 Jun;15(2):209-215.
- doi: 10.3350/kjhep.2009.15.2.209
A 63-year-old male experienced sudden diplopia after 9 weeks of administration of pegylated interferon (IFN) alpha-2b and ribavirin for chronic hepatitis C (CHC). Ophthalmologic examinations showed ptosis on the right... -
- CITED
-
- Close
- SHARE
-
- Close
- Liver Stiffness Measurement for the Diagnosis of Hepatic Fibrosis in Patients with Chronic Viral Hepatitis
-
Kang JK, Cheong JY, Cho SW, Cho JH, Park JS, Kim YB, Kim DJ, Hwang SG, Yang JM, Park YN
- KMID: 1776828
- Korean J Hepatol.
- 2007 Dec;13(4):521-529.
- doi: 10.3350/kjhep.2007.13.4.521
BACKGROUND AND AIMS: FibroScan(R) is a new medical device that noninvasively measures liver stiffness. The aim of this study was to assess the accuracy of the liver stiffness measurement... -
- CITED
-
- Close
- SHARE
-
- Close
- Clinical features and treatment efficacy of peginterferon alfa plus ribavirin in chronic hepatitis C patients coinfected with hepatitis B virus
-
Kim YJ, Lee JW, Kim YS, Jeong SH, Kim YS, Yim HJ, Kim BH, Lee CK, Park CK, Park SH
- KMID: 1025199
- Korean J Hepatol.
- 2011 Sep;17(3):199-205.
- doi: 10.3350/kjhep.2011.17.3.199
BACKGROUND/AIMS: Cross-sectional studies have documented that 2-10% of patients who are chronically infected with hepatitis C virus (HCV) are also positive for hepatitis B virus (HBV) surface antigen (HBsAg). Data... -
- CITED
-
- Close
- SHARE
-
- Close
- Therapy with Direct-Acting Antiviral Agents for Hepatitis C-Related Liver Cirrhosis
-
Toshikuni
- KMID: 2412206
- Gut Liver.
- 2017 May;11(3):335-348.
- doi: 10.5009/gnl15458
Chronic hepatitis C virus (HCV) infection may eventually lead to liver cirrhosis (LC), a condition associated with a high risk of liver failure and hepatocellular carcinoma. Although interferon (IFN)-based therapy... -
- CITED
-
- Close
- SHARE
-
- Close
- Treatment Response and Long-Term Outcome of Peginterferon α and Ribavirin Therapy in Korean Patients with Chronic Hepatitis C
-
Jung CH, Um SH, Kim TH, Yim SY, Suh SJ, Yim HJ, Seo YS, Choi HS, Chun HJ
- KMID: 2412080
- Gut Liver.
- 2016 Sep;10(5):808-817.
- doi: 10.5009/gnl15360
BACKGROUND/AIMS: Peginterferon plus ribavirin remains a standard therapy for patients with chronic hepatitis C (CHC) in Korea. We investigated the efficacy and long-term outcome of peginterferon and ribavirin therapy in... -
- CITED
-
- Close
- SHARE
-
- Close
- Hepatitis C virus (HCV) genotypes and the influence of HCV subtype 1b on the progression of chronic hepatitis C in Korea: a single center experience
-
Cho EJ, Jeong SH, Han BH, Lee SU, Yun BC, Park ET
- KMID: 1743730
- Clin Mol Hepatol.
- 2012 Jun;18(2):219-224.
- doi: 10.3350/cmh.2012.18.2.219
BACKGROUND/AIMS: There is some controversy regarding whether or not hepatitis C virus (HCV) subtype 1b is more influential than non-1b subtypes on the progression of chronic hepatitis (CH) C to... -
- CITED
-
- Close
- SHARE
-
- Close
- Hepatic perivascular epithelioid cell tumor (PEComa): a case report with a review of literatures
-
Son HJ, Kang DW, Kim JH, Han HY, Lee MK
- KMID: 2412118
- Clin Mol Hepatol.
- 2017 Mar;23(1):80-86.
- doi: 10.3350/cmh.2016.0034
Hepatic perivascular epithelioid cell tumors (PEComas) are very rare. We report a primary hepatic PEComa with a review of the literature. A 56-year-old women presented with a nodular mass detected... -
- CITED
-
- Close
- SHARE
-
- Close
- Hepatic myelopathy as a presenting neurological complication in patients with cirrhosis and spontaneous splenorenal shunt
-
Koo JE, Lim YS, Myung SJ, Suh KS, Kim KM, Lee HC, Chung YH, Lee YS, Suh DJ
- KMID: 1073333
- Korean J Hepatol.
- 2008 Mar;14(1):89-96.
- doi: 10.3350/kjhep.2008.14.1.89
Hepatic myelopathy is a rare complication of chronic liver disease that is associated with extensive portosystemic shunts. The main clinical feature of hepatic myelopathy is progressive spastic paraparesis in the... -
- CITED
-
- Close
- SHARE
-
- Close
- Highly effective peginterferon alpha-2a plus ribavirin combination therapy for chronic hepatitis C in hemophilia in Korea
-
Yang SY, Lee HW, Lee YJ, Park SJ, Yoo KY, Kim HJ
- KMID: 2164362
- Clin Mol Hepatol.
- 2015 Jun;21(2):125-130.
- doi: 10.3350/cmh.2015.21.2.125
BACKGROUND/AIMS: Chronic hepatitis C (CHC) is a major comorbidity in patients with hemophilia. However, there are no published data on the efficacy of antiviral therapy in Korea. We assessed the... -
- CITED
-
- Close
- SHARE
-
- Close
- A Case of Cryptococcal Meningitis Mimicking Hepatic Encephalopathy in a Patient with Liver Cirrhosis Caused by Chronic Hepatitis C
-
Choi HM, Jung GM, Lee WK, Lee HS, Kim BS, Seong CS, Yoon SH, Cho YK
- KMID: 2164433
- Korean J Gastroenterol.
- 2014 Nov;64(5):294-297.
- doi: 10.4166/kjg.2014.64.5.294
Cryptococcus neoformans, an encapsulated fungus, is an important opportunistic pathogen that can cause meningitis in immunocompromised patients. Since patients with cryptococcemia have high mortality, it is essential to make an... -
- CITED
-
- Close
- SHARE
-
- Close
- Sofosbuvir-based therapy for patients with chronic hepatitis C: Early experience of its efficacy and safety in Korea
-
Cho Y, Cho EJ, Lee JH, Yu SJ, Yoon JH, Kim YJ
- KMID: 2359817
- Clin Mol Hepatol.
- 2015 Dec;21(4):358-364.
- doi: 10.3350/cmh.2015.21.4.358
BACKGROUND/AIMS: The previous standard treatment for chronic hepatitis C (CHC) patients, comprising a combination of pegylated interferon (IFN) and ribavirin, was associated with suboptimal efficacy and severe adverse reactions. A... -
- CITED
-
- Close
- SHARE
-
- Close
- Clinical efficacy and safety of the combination therapy of peginterferon alpha and ribavirin in cirrhotic patients with HCV infection
-
Cheong HR, Woo HY, Heo J, Yoon KT, Kim DU, Kim GH, Kang DH, Song GA, Cho M
- KMID: 1782219
- Korean J Hepatol.
- 2010 Mar;16(1):38-48.
- doi: 10.3350/kjhep.2010.16.1.38
BACKGROUND/AIMS: The combination therapy of peginterferon (PEG-IFN) and ribavirin is the standard treatment for hepatitis C virus (HCV) infection. However, few trials have involved patients with cirrhosis. The purpose of... -
- CITED
-
- Close
- SHARE
-
- Close
